Advertisement

Clinical Autonomic Research

, Volume 26, Issue 4, pp 279–285 | Cite as

Assessment of autonomic function in a cohort of patients with ANCA-associated vasculitis

  • P. Moog
  • O. Eren
  • M. Witt
  • V. Rauschel
  • S. Kossegg
  • A. Straube
  • M. Grünke
  • H. Schulze-Koops
Research Article

Abstract

Objective

To assess symptoms and objective parameters of autonomic dysfunction (AD) in patients with ANCA-associated vasculitides.

Methods

Symptoms and objective parameters of AD were assessed in patients with ANCA-associated vasculitis and in age-matched healthy controls. Autonomic symptoms were explored by COMPASS31, a validated questionnaire addressing symptoms of six autonomic domains (orthostatic, vasomotor, secretomotor, gastrointestinal, pupillomotor, and bladder dysfunction). Objective autonomic parameters consisted of expiratory/inspiratory (E/I) ratio during the deep breathing test (DBT), blood pressure response to cold pressor test (CPT), and skin conductance changes during mental arithmetic.

Results

27 patients and 27 healthy controls have been enrolled. 27 patients and 27 controls completed COMPASS31. 21 patients and 18 controls underwent objective autonomic testing. Vasculitis patients had significantly higher COMPASS31 total scores than controls (median 10.4 vs 3.0; p = 0.005). In the sub-domain analysis, significant differences were seen in the vasomotor and the bladder domain (p = 0.004; p < 0.001, respectively). No correlation was found between COMPASS31 score and disease duration, number of affected organs, or Birmingham vasculitis activity score (BVAS). There was no significant difference in any of the objective autonomic parameters between patients and controls. In a subgroup analysis, no difference in objective autonomic parameters was found between patients with active disease (n = 12) and patients in remission (n = 7).

Conclusion

Patients with ANCA-associated vasculitides commonly have symptoms of autonomic dysfunction that are independent of disease duration and disease severity. However, at least in this single-centre observation, there was no evidence of impaired autonomic regulation in three autonomic function tests in vasculitis patients.

Keywords

ANCA Vasculitis Granulomatosis with polyangiitis Microscopic polyangiitis Autonomic neuropathy Autonomic dysfunction Heart rate variability 

Notes

Compliance with ethical standards

Conflict of interest

No conflicts of interest.

References

  1. 1.
    Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354–381CrossRefGoogle Scholar
  2. 2.
    Alba MA, Moreno-Palacios J, Beca S, Cid MC (2015) Urologic and male genital manifestations of granulomatosis with polyangiitis. Autoimmun Rev 14:897–902CrossRefPubMedGoogle Scholar
  3. 3.
    Bernardi L, Ricordi L, Lazzari P, Solda P, Calciati A, Ferrari MR, Vandea I, Finardi G, Fratino P (1992) Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation 86:1443–1452CrossRefPubMedGoogle Scholar
  4. 4.
    Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB (2004) Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation 109:1718–1723CrossRefPubMedGoogle Scholar
  5. 5.
    Bruce IN, Harris CM, Nugent A, McDermott BJ, Johnston GD, Bell AL (1997) Enhanced endothelium-dependent vasodilator responses in patients with systemic vasculitis. Scand J Rheumatol 26:318–324PubMedGoogle Scholar
  6. 6.
    Cohen Tervaert JW (2013) Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides. Best Pract Res Clin Rheumatol 27:33–44CrossRefPubMedGoogle Scholar
  7. 7.
    Dufour JF, Le Gallou T, Cordier JF, Aumaitre O, Pinede L, Aslangul E, Pagnoux C, Marie I, Puechal X, Decaux O, Dubois A, Agard C, Mahr A, Comoz F, Boutemy J, Broussolle C, Guillevin L, Seve P, Bienvenu B (2012) Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature. Medicine (Baltimore) 91:67–74CrossRefGoogle Scholar
  8. 8.
    Faurschou M, Mellemkjaer L, Sorensen IJ, Svalgaard Thomsen B, Dreyer L, Baslund B (2009) Increased morbidity from ischemic heart disease in patients with Wegener’s granulomatosis. Arthritis Rheum 60:1187–1192CrossRefPubMedGoogle Scholar
  9. 9.
    Filer AD, Gardner-Medwin JM, Thambyrajah J, Raza K, Carruthers DM, Stevens RJ, Liu L, Lowe SE, Townend JN, Bacon PA (2003) Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 62:162–167CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gang Y, Malik M (2002) Heart rate variability in critical care medicine. Curr Opin Crit Care 8:371–375CrossRefPubMedGoogle Scholar
  11. 11.
    Huong DL, Papo T, Piette JC, Wechsler B, Bletry O, Richard F, Valcke JC, Godeau P (1995) Urogenital manifestations of Wegener granulomatosis. Medicine (Baltimore) 74:152–161CrossRefGoogle Scholar
  12. 12.
    Laederach-Hofmann K, Mussgay L, Ruddel H (2000) Autonomic cardiovascular regulation in obesity. J Endocrinol 164:59–66CrossRefPubMedGoogle Scholar
  13. 13.
    Louthrenoo W, Ruttanaumpawan P, Aramrattana A, Sukitawut W (1999) Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus. QJM 92:97–102CrossRefPubMedGoogle Scholar
  14. 14.
    Mandl T, Granberg V, Apelqvist J, Wollmer P, Manthorpe R, Jacobsson LT (2008) Autonomic nervous symptoms in primary Sjogren’s syndrome. Rheumatology (Oxford) 47:914–919CrossRefGoogle Scholar
  15. 15.
    Morgan MD, Turnbull J, Selamet U, Kaur-Hayer M, Nightingale P, Ferro CJ, Savage CO, Harper L (2009) Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. Arthritis Rheum 60:3493–3500CrossRefPubMedGoogle Scholar
  16. 16.
    Newton JL, Frith J, Powell D, Hackett K, Wilton K, Bowman S, Price E, Pease C, Andrews J, Emery P, Hunter J, Gupta M, Vadivelu S, Giles I, Isenberg D, Lanyon P, Jones A, Regan M, Cooper A, Moots R, Sutcliffe N, Bombardieri M, Pitzalis C, McLaren J, Young-Min S, Dasgupta B, Griffiths B, Lendrem D, Mitchell S, Ng WF (2012) Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren’s syndrome. Ann Rheum Dis 71:1973–1979CrossRefPubMedGoogle Scholar
  17. 17.
    Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33:4–9CrossRefPubMedGoogle Scholar
  18. 18.
    Nomura A, Kishimoto M, Takahashi O, Deshpande GA, Yamaguchi K, Okada M (2013) Prolongation of heart rate-corrected QT interval is a predictor of cardiac autonomic dysfunction in patients with systemic lupus erythematosus. Rheumatol Int 34(5):643–647CrossRefPubMedGoogle Scholar
  19. 19.
    Pop-Busui R, Cleary PA, Braffett BH, Martin CL, Herman WH, Low PA, Lima JA, Bluemke DA (2013) Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (diabetes control and complications trial/epidemiology of diabetes interventions and complications). J Am Coll Cardiol 61:447–454CrossRefPubMedGoogle Scholar
  20. 20.
    Shalimar Handa R, Deepak KK, Bhatia M, Aggarwal P, Pandey RM (2006) Autonomic dysfunction in systemic lupus erythematosus. Rheumatol Int 26:837–840CrossRefPubMedGoogle Scholar
  21. 21.
    Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W (2012) COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc 87:1196–1201CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Stojanovich L (2009) Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev 8:569–572CrossRefPubMedGoogle Scholar
  23. 23.
    Suppiah R, Judge A, Batra R, Flossmann O, Harper L, Hoglund P, Javaid MK, Jayne D, Mukhtyar C, Westman K, Davis JC Jr, Hoffman GS, McCune WJ, Merkel PA, St Clair EW, Seo P, Spiera R, Stone JH, Luqmani R (2011) A model to predict cardiovascular events in patients with newly diagnosed Wegener’s granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken) 63:588–596CrossRefGoogle Scholar
  24. 24.
    Wang CC, Weng TI, Wu ET, Wu MH, Yang RS, Liu SH (2013) Involvement of interleukin-6-regulated nitric oxide synthase in hemorrhagic cystitis and impaired bladder contractions in young rats induced by acrolein, a urinary metabolite of cyclophosphamide. Toxicol Sci 131:302–310CrossRefPubMedGoogle Scholar
  25. 25.
    Ziegler D, Strom A, Strassburger K, Nowotny B, Zahiragic L, Nowotny PJ, Carstensen-Kirberg M, Herder C, Szendroedi J, Roden M (2015) Differential patterns and determinants of cardiac autonomic nerve dysfunction during endotoxemia and oral fat load in humans. PLoS One 10:e0124242CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Zinger H, Sherer Y, Shoenfeld Y (2009) Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings. Clin Rev Allergy Immunol 37:20–28CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • P. Moog
    • 1
    • 3
  • O. Eren
    • 2
  • M. Witt
    • 1
  • V. Rauschel
    • 2
  • S. Kossegg
    • 1
  • A. Straube
    • 2
  • M. Grünke
    • 1
  • H. Schulze-Koops
    • 1
  1. 1.Medizinische Klinik IV, RheumaeinheitKlinikum der Universität MünchenMunichGermany
  2. 2.Neurologische Klinik und PoliklinikKlinikum der Universität MünchenMunichGermany
  3. 3.Abteilung für NephrologieKlinikum rechts der Isar, Technische Universität MünchenMunichGermany

Personalised recommendations